Description of included studies
| Direct morbidity (n=52) (%) | Indirect morbidity (n=84) (%) | Total (n=136) (%) | |
| Region | |||
| Africa | 5.8 | 15.5 | 11.8 |
| Asia | 15.4 | 20.2 | 18.4 |
| Europe | 48.1 | 26.2 | 34.6 |
| Latin America and the Caribbean | 3.8 | 6.0 | 5.1 |
| North America | 13.5 | 26.2 | 21.3 |
| Oceania | 7.7 | 3.6 | 5.1 |
| Multiple | 5.8 | 2.4 | 3.7 |
| Timing of assessment of functioning | |||
| Antepartum | 19.2 | 27.4 | 24.3 |
| Antepartum and postpartum | 11.5 | 7.1 | 8.8 |
| Postpartum (≤1 year) | 26.9 | 42.9 | 36.8 |
| Postpartum (>1 year) | 23.1 | 6.0 | 12.5 |
| Postpartum (both ≤1 year and >1 year) | 7.7 | 11.9 | 10.3 |
| Postpartum (unknown) | 1.9 | 2.4 | 2.2 |
| Not specified | 9.6 | 2.4 | 5.1 |
| Study design | |||
| Cohort | 63.5 | 40.5 | 49.3 |
| Cross sectional | 23.1 | 41.7 | 34.6 |
| Trial | 7.7 | 15.5 | 12.5 |
| Case–control | 5.8 | 2.4 | 3.7 |
| Comparison (control) group relevant to maternal morbidity and functioning | |||
| Yes | 61.5 | 48.8 | 53.7 |
| No | 38.5 | 51.2 | 46.3 |
| Total | 100 | 100 | 100 |